Tredje AP-fonden’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122M | Sell |
559,089
-103,754
| -16% | -$23M | 0.67% | 21 |
|
|
2025
Q4 | $151M | Sell |
662,843
-102,945
| -13% | -$23.5M | 1.14% | 15 |
|
|
2025
Q3 | $177M | Buy |
765,788
+54,596
| +8% | +$11.1M | 1.42% | 12 |
|
|
2025
Q2 | $132M | Sell |
711,192
-42,946
| -6% | -$7.98M | 1.05% | 17 |
|
|
2025
Q1 | $158M | Buy |
754,138
+4,680
| +0.6% | +$910K | 1.48% | 11 |
|
|
2024
Q4 | $133M | Buy |
749,458
+16,338
| +2% | +$3M | 1.2% | 17 |
|
|
2024
Q3 | $145M | Buy |
733,120
+18,890
| +3% | +$3.53M | 1.31% | 14 |
|
|
2024
Q2 | $123M | Buy |
714,230
+170,500
| +31% | +$28.2M | 1.18% | 15 |
|
|
2024
Q1 | $99M | Buy |
543,730
+46,300
| +9% | +$7.98M | 1.03% | 22 |
|
|
2023
Q4 | $77.1M | Sell |
497,430
-37,440
| -7% | -$5.46M | 0.96% | 19 |
|
|
2023
Q3 | $79.7M | Sell |
534,870
-718
| -0.1% | -$105K | 1.18% | 12 |
|
|
2023
Q2 | $72.2M | Buy |
535,588
+30,364
| +6% | +$4.45M | 1.02% | 18 |
|
|
2023
Q1 | $80.5M | Buy |
505,224
+27,654
| +6% | +$4.23M | 1.25% | 12 |
|
|
2022
Q4 | $77.2M | Sell |
477,570
-38,018
| -7% | -$5.83M | 1.32% | 13 |
|
|
2022
Q3 | $69.2M | Buy |
515,588
+231,097
| +81% | +$33.2M | 1.43% | 9 |
|
|
2022
Q2 | $43.6M | Sell |
284,491
-128,000
| -31% | -$19.6M | 1.1% | 16 |
|
|
2022
Q1 | $66.9M | Sell |
412,491
-2,000
| -0.5% | -$291K | 1.36% | 12 |
|
|
2021
Q4 | $56.1M | Sell |
414,491
-76,828
| -16% | -$9.08M | 1.08% | 16 |
|
|
2021
Q3 | $53M | Sell |
491,319
-340,000
| -41% | -$38.9M | 1.11% | 16 |
|
|
2021
Q2 | $93.6M | Buy |
831,319
+98,000
| +13% | +$11M | 1.91% | 9 |
|
|
2021
Q1 | $79.4M | Buy |
733,319
+168,000
| +30% | +$18M | 1.89% | 10 |
|
|
2020
Q4 | $60.6M | Sell |
565,319
-5,000
| -0.9% | -$480K | 1.56% | 12 |
|
|
2020
Q3 | $50M | Buy |
570,319
+30,000
| +6% | +$2.82M | 1.62% | 12 |
|
|
2020
Q2 | $53M | Buy |
540,319
+321,183
| +147% | +$28.3M | 2.2% | 9 |
|
|
2020
Q1 | $16.7M | Buy |
219,136
+37,027
| +20% | +$3.15M | 0.87% | 28 |
|
|
2019
Q4 | $16.1M | Sell |
182,109
-21,342
| -10% | -$1.77M | 0.82% | 30 |
|
|
2019
Q3 | $15.4M | Sell |
203,451
-16,451
| -7% | -$1.13M | 0.74% | 32 |
|
|
2019
Q2 | $16M | Buy |
219,902
+19,907
| +10% | +$1.56M | 0.76% | 31 |
|
|
2019
Q1 | $16.1M | Buy |
199,995
+20,496
| +11% | +$1.68M | 0.83% | 30 |
|
|
2018
Q4 | $16.5M | Sell |
179,499
-77,827
| -30% | -$6.84M | 1.01% | 19 |
|
|
2018
Q3 | $24.3M | Sell |
257,326
-1,000
| -0.4% | -$94.8K | 1.17% | 14 |
|
|
2018
Q2 | $23.9M | Sell |
258,326
-50,809
| -16% | -$4.96M | 0.83% | 21 |
|
|
2018
Q1 | $29.3M | Buy |
309,135
+8,700
| +3% | +$956K | 1.04% | 11 |
|
|
2017
Q4 | $29.1M | Buy |
300,435
+1,170
| +0.4% | +$110K | 0.99% | 10 |
|
|
2017
Q3 | $26.6M | Buy |
299,265
+15,440
| +5% | +$1.18M | 0.94% | 8 |
|
|
2017
Q2 | $20.6M | Sell |
283,825
-3,040
| -1% | -$204K | 0.77% | 18 |
|
|
2017
Q1 | $18.7M | Buy |
286,865
+5,721
| +2% | +$360K | 0.74% | 20 |
|
|
2016
Q4 | $17.6M | Sell |
281,144
-6,933
| -2% | -$423K | 0.74% | 21 |
|
|
2016
Q3 | $18.2M | Sell |
288,077
-14,324
| -5% | -$927K | 0.82% | 18 |
|
|
2016
Q2 | $18.7M | Sell |
302,401
-21,004
| -6% | -$1.28M | 0.84% | 22 |
|
|
2016
Q1 | $20.5M | Sell |
323,405
-147,187
| -31% | -$8.2M | 0.93% | 24 |
|
|
2015
Q4 | $27.9M | Buy |
470,592
+11,754
| +3% | +$677K | 1.79% | 7 |
|
|
2015
Q3 | $25M | Buy |
458,838
+63,056
| +16% | +$4.1M | 2.44% | 3 |
|
|
2015
Q2 | $26.6M | Buy |
+395,782
| New | +$25.8M | 2.13% | 3 |
|
Other funds holding ABBV
VCM
VPM
Tredje AP-fonden's ABBV Position: Q1 2026 in Review
Tredje AP-fonden reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $23M and leaving 559,089 shares worth $122M. The position accounts for 0.67% of the portfolio, ranked #21.
Tredje AP-fonden first reported a position in ABBV in Q2 2015 and has held it in 44 quarters since. The position peaked at $177M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Tredje AP-fonden held 559,089 shares of AbbVie worth $122M as of Q1 2026.
- Tredje AP-fonden sold 103,754 AbbVie shares in Q1 2026, an estimated $23M.
- AbbVie made up 0.67% of Tredje AP-fonden's portfolio in Q1 2026, its #21 holding.
- Tredje AP-fonden first reported a position in AbbVie in Q2 2015 and has held it in 44 quarters since.
- Tredje AP-fonden's AbbVie position peaked at $177M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Tredje AP-fonden's 13F filing for Q1 2026, filed 12 May 2026.